FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1977614360> ?p ?o ?g. }

• W1977614360 endingPage "300" @default.
• W1977614360 startingPage "291" @default.
• W1977614360 abstract "Sorafenib is a vascular endothelial growth factor receptor tyrosine-kinase inhibitor currently used in several malignancies. While not a traditional cytotoxic chemotherapeutic agent, hematological toxicities have been reported with this drug but the incidence and risk have not been formerly assessed. We performed a meta-analysis to determine the incidence and risk of hematologic toxicities associated with sorafenib use. The databases of Medline were searched for articles from 1966 to May 2010. Abstracts presented at the American Society of Clinical Oncology meetings were also searched. Eligible studies include randomized trials with sorafenib, and adequate safety data profile reporting anemia, neutropenia, lymphopenia or thrombocytopenia. Statistical analyses were conducted to calculate the summary incidence, RR and 95% confidence intervals (CI). A total of 3221 patients were included. The incidences of sorafenib-associated all-grade anemia, neutropenia, thrombocytopenia and lymphopenia were 43.9%, 18.0%, 25.3% and 34.1%, respectively. The incidences of high-grade events were 2.0%, 5.1%, 4.0% and 13.1%, respectively. Sorafenib was associated with a decreased risk of high-grade anemia (RR = 0.62; 95% CI, 0.39–0.98), an increased risk of all-grade (RR = 1.69; 95% CI, 1.33–2.17) and high-grade (RR = 1.61; 95% CI, 1.02–2.57) neutropenia, all-grade (RR = 2.56; 95% CI, 1.37–4.80) and high-grade (RR = 3.63; 95% CI, 1.98–6.66) thrombocytopenia, and high-grade lymphopenia (RR = 1.84; 95% CI, 1.22–2.78). Stratified analysis by the presence or not of concomitant chemotherapy demonstrated similar risks. Independent of cytotoxic chemotherapy, sorafenib has significant hematologic toxicities, with a decreased risk of anemia and increased risk of neutropenia, thrombocytopenia and lymphopenia." @default.
• W1977614360 created "2016-06-24" @default.
• W1977614360 creator A5018055906 @default.
• W1977614360 creator A5052504518 @default.
• W1977614360 creator A5091352250 @default.
• W1977614360 date "2011-11-01" @default.
• W1977614360 modified "2023-10-18" @default.
• W1977614360 title "Hematologic toxicities in cancer patients treated with the multi-tyrosine kinase sorafenib: A meta-analysis of clinical trials" @default.
• W1977614360 cites W1600542667 @default.
• W1977614360 cites W1963876488 @default.
• W1977614360 cites W1964435302 @default.
• W1977614360 cites W1971833736 @default.
• W1977614360 cites W1971837077 @default.
• W1977614360 cites W1987073370 @default.
• W1977614360 cites W1994193851 @default.
• W1977614360 cites W2004907588 @default.
• W1977614360 cites W2029722796 @default.
• W1977614360 cites W204046373 @default.
• W1977614360 cites W2045260833 @default.
• W1977614360 cites W2046516822 @default.
• W1977614360 cites W2056802932 @default.
• W1977614360 cites W2061345986 @default.
• W1977614360 cites W2069417222 @default.
• W1977614360 cites W2073363047 @default.
• W1977614360 cites W2073363483 @default.
• W1977614360 cites W2107328434 @default.
• W1977614360 cites W2125131568 @default.
• W1977614360 cites W2125435699 @default.
• W1977614360 cites W2126621994 @default.
• W1977614360 cites W2126970264 @default.
• W1977614360 cites W2131754429 @default.
• W1977614360 cites W2133450550 @default.
• W1977614360 cites W2135057615 @default.
• W1977614360 cites W2137196869 @default.
• W1977614360 cites W2139684524 @default.
• W1977614360 cites W2145704036 @default.
• W1977614360 cites W2147186814 @default.
• W1977614360 cites W2157262448 @default.
• W1977614360 cites W2157823046 @default.
• W1977614360 cites W2159370421 @default.
• W1977614360 cites W2159483734 @default.
• W1977614360 cites W2162424705 @default.
• W1977614360 cites W2166742462 @default.
• W1977614360 cites W2171484579 @default.
• W1977614360 cites W2280729002 @default.
• W1977614360 cites W2424714590 @default.
• W1977614360 cites W2468996569 @default.
• W1977614360 doi "https://doi.org/10.1016/j.critrevonc.2010.11.007" @default.
• W1977614360 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21339073" @default.
• W1977614360 hasPublicationYear "2011" @default.
• W1977614360 type Work @default.
• W1977614360 sameAs 1977614360 @default.
• W1977614360 citedByCount "50" @default.
• W1977614360 countsByYear W19776143602012 @default.
• W1977614360 countsByYear W19776143602013 @default.
• W1977614360 countsByYear W19776143602014 @default.
• W1977614360 countsByYear W19776143602015 @default.
• W1977614360 countsByYear W19776143602016 @default.
• W1977614360 countsByYear W19776143602017 @default.
• W1977614360 countsByYear W19776143602018 @default.
• W1977614360 countsByYear W19776143602019 @default.
• W1977614360 countsByYear W19776143602020 @default.
• W1977614360 countsByYear W19776143602021 @default.
• W1977614360 countsByYear W19776143602022 @default.
• W1977614360 crossrefType "journal-article" @default.
• W1977614360 hasAuthorship W1977614360A5018055906 @default.
• W1977614360 hasAuthorship W1977614360A5052504518 @default.
• W1977614360 hasAuthorship W1977614360A5091352250 @default.
• W1977614360 hasConcept C120665830 @default.
• W1977614360 hasConcept C121332964 @default.
• W1977614360 hasConcept C126322002 @default.
• W1977614360 hasConcept C143998085 @default.
• W1977614360 hasConcept C2776694085 @default.
• W1977614360 hasConcept C2777063308 @default.
• W1977614360 hasConcept C2778019345 @default.
• W1977614360 hasConcept C2778248108 @default.
• W1977614360 hasConcept C2778695046 @default.
• W1977614360 hasConcept C44249647 @default.
• W1977614360 hasConcept C61511704 @default.
• W1977614360 hasConcept C71924100 @default.
• W1977614360 hasConcept C82789193 @default.
• W1977614360 hasConcept C90924648 @default.
• W1977614360 hasConceptScore W1977614360C120665830 @default.
• W1977614360 hasConceptScore W1977614360C121332964 @default.
• W1977614360 hasConceptScore W1977614360C126322002 @default.
• W1977614360 hasConceptScore W1977614360C143998085 @default.
• W1977614360 hasConceptScore W1977614360C2776694085 @default.
• W1977614360 hasConceptScore W1977614360C2777063308 @default.
• W1977614360 hasConceptScore W1977614360C2778019345 @default.
• W1977614360 hasConceptScore W1977614360C2778248108 @default.
• W1977614360 hasConceptScore W1977614360C2778695046 @default.
• W1977614360 hasConceptScore W1977614360C44249647 @default.
• W1977614360 hasConceptScore W1977614360C61511704 @default.
• W1977614360 hasConceptScore W1977614360C71924100 @default.
• W1977614360 hasConceptScore W1977614360C82789193 @default.
• W1977614360 hasConceptScore W1977614360C90924648 @default.
• W1977614360 hasIssue "2" @default.
• W1977614360 hasLocation W19776143601 @default.

• next